# Pediatric Ovarian & Gynecologic Tumors — GCMD Library living collection

Updated: n/a · 8 episodes · 34 cited statements

## Episodes
### Risk Stratification & Diagnosis
- [Use of Radiographic Features for Risk Stratification of Ovarian Masses in Children and Adolescents](https://library.globalcastmd.com/article/use-of-radiographic-features-for-risk-stratification-of-ovarian-masses-in-childr-16403) — article · [machine version](https://library.globalcastmd.com/article/use-of-radiographic-features-for-risk-stratification-of-ovarian-masses-in-childr-16403.md)
- [Use of Ovarian Tumor Markers in Prediction of Malignancy Risk in Pediatric and Adolescent Patients](https://library.globalcastmd.com/watch/use-of-ovarian-tumor-markers-in-prediction-of-malignancy-risk-in-pediatric-and-a-11862) — video · 0:53 · [machine version](https://library.globalcastmd.com/watch/use-of-ovarian-tumor-markers-in-prediction-of-malignancy-risk-in-pediatric-and-a-11862.md)

### Surgical Management
- [Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients](https://library.globalcastmd.com/article/reducing-unnecessary-oophorectomies-for-benign-ovarian-neoplasms-in-pediatric-pa-7770) — article · [machine version](https://library.globalcastmd.com/article/reducing-unnecessary-oophorectomies-for-benign-ovarian-neoplasms-in-pediatric-pa-7770.md)

### Specific Tumor Types
- [Atypical Presentation of Granulosa Cell Tumor in an Adolescent: A Case Report.](https://library.globalcastmd.com/article/atypical-presentation-of-granulosa-cell-tumor-in-an-adolescent-a-case-report-16984) — article · [machine version](https://library.globalcastmd.com/article/atypical-presentation-of-granulosa-cell-tumor-in-an-adolescent-a-case-report-16984.md)
- [Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4](https://library.globalcastmd.com/article/small-cell-carcinoma-of-the-ovary-hypercalcemic-type-displays-frequent-inactivat-17032) — article · [machine version](https://library.globalcastmd.com/article/small-cell-carcinoma-of-the-ovary-hypercalcemic-type-displays-frequent-inactivat-17032.md)
- [Successful treatment of preadolescents with small cell carcinoma of the ovary hypercalcemic type](https://library.globalcastmd.com/article/successful-treatment-of-preadolescents-with-small-cell-carcinoma-of-the-ovary-hy-17033) — article · [machine version](https://library.globalcastmd.com/article/successful-treatment-of-preadolescents-with-small-cell-carcinoma-of-the-ovary-hy-17033.md)
- [Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult](https://library.globalcastmd.com/article/small-cell-carcinoma-of-the-ovary-hypercalcemic-type-comprehensive-management-of-17019) — article · [machine version](https://library.globalcastmd.com/article/small-cell-carcinoma-of-the-ovary-hypercalcemic-type-comprehensive-management-of-17019.md)
- [Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.](https://library.globalcastmd.com/article/small-cell-carcinoma-of-the-ovary-hypercalcemic-type-a-review-and-novel-case-wit-17009) — article · [machine version](https://library.globalcastmd.com/article/small-cell-carcinoma-of-the-ovary-hypercalcemic-type-a-review-and-novel-case-wit-17009.md)

## Statements
Every statement is attributed, typed, and timestamped; the link is the citation.
- Most ovarian masses in children and adolescents are benign. (established) (no timestamp yet)
- Unnecessary oophorectomy can have lifelong negative effects on health. (established) (no timestamp yet)
- The study included patients aged 6 to 21 years undergoing surgery for an ovarian mass across 11 children's hospitals in the United States between August 2018 and January 2021. (research) (no timestamp yet)
- Benign disease was present in 93 (96.9%) patients in the preintervention cohort and 298 (93.7%) in the intervention cohort. (research) (no timestamp yet)
- The percentage of unnecessary oophorectomies decreased from 16.1% preintervention to 8.4% during the intervention, an absolute reduction of 7.7%. (research) (no timestamp yet)
- The algorithm achieved a sensitivity of 91.6% for identifying benign lesions in the intervention cohort. (research) (no timestamp yet)
- The algorithm achieved a specificity of 90.0% for identifying benign lesions in the intervention cohort. (research) (no timestamp yet)
- The algorithm achieved a positive predictive value of 99.3% for identifying benign lesions in the intervention cohort. (research) (no timestamp yet)
- The algorithm achieved a negative predictive value of 41.9% for identifying benign lesions in the intervention cohort. (research) (no timestamp yet)
- The proportion of misclassification in the intervention phase, defined as malignant disease treated with ovary-sparing surgery, was 0.7%. (research) (no timestamp yet)
- Algorithm adherence during the intervention phase was 95.0%, with fidelity of 81.8%. (research) (no timestamp yet)
- Use of a preoperative risk stratification algorithm to identify lesions with a high likelihood of benign pathology can reduce unnecessary oophorectomies. (recommendation) (no timestamp yet)
- Radiographic features suspicious for malignancy should prompt further evaluation including a multidisciplinary discussion for consideration of ovarian sparing surgery versus oophorectomy. (recommendation) (no timestamp yet)
- The presence of a complex mass, solid component, or tumor size greater than 8 cm was reported in 26 of 27 malignant tumors. (research) (no timestamp yet)
- All 26 malignant tumors were identified when one of these radiographic features (complex mass, solid component, or tumor size greater than 8 cm) was present, conferring a negative predictive value of 100% with 65.1% accuracy. (research) (no timestamp yet)
- The combination of radiographic evidence of metastatic disease and increased β-human gonadotropin, cancer antigen 125, or inhibin A identified all malignant tumors. (research) (no timestamp yet)
- Granulosa cell tumors frequently present with elevated levels of estrogen and inhibin. (established) (no timestamp yet)
- Most diagnoses of granulosa cell tumors in the pediatric and adolescent population are juvenile-type; adult-type granulosa cell tumors in this population are rare. (established) (no timestamp yet)
- A 14-year-old female presented with a large adnexal mass and clinical hyperandrogenism with elevated levels of free and total testosterone. (research) (no timestamp yet)
- Small cell carcinoma of the ovary hypercalcemic type (SCCOHT) is a rare and aggressive disease. (established) (no timestamp yet)
- SCCOHT is classically linked to mutations in SMARCA4. (established) (no timestamp yet)
- A case of SCCOHT has been identified in a patient with both SMARCA4 and BRCA2 germline mutations. (research) (no timestamp yet)
- Treatment approaches for SCCOHT include adjuvant systemic chemotherapy, interval hyperthermic intraperitoneal chemotherapy, and high-dose chemotherapy. (research) (no timestamp yet)
- Small cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is an extremely rare, aggressive cancer affecting children and young women. (established) (no timestamp yet)
- Germline and somatic inactivating mutations in the SWI/SNF chromatin-remodeling gene SMARCA4 were identified in 75% (9/12) of SCCOHT cases. (research) (no timestamp yet)
- SMARCA4 protein loss was found in 82% (14/17) of SCCOHT tumors. (research) (no timestamp yet)
- SMARCA4 protein loss was found in only 0.4% (2/485) of other primary ovarian tumors. (research) (no timestamp yet)
- SMARCA4 is implicated in SCCOHT oncogenesis. (research) (no timestamp yet)
- Small cell carcinoma of the ovary hypercalcemic type is a rare tumor with a peak incidence in young adulthood that historically has carried a poor prognosis. (established) (no timestamp yet)
- Two advanced stage cases of SCCOHT in preadolescents were successfully treated with a combination of cisplatin-based chemotherapy and surgical resection. (research) (no timestamp yet)
- One patient underwent consolidative high-dose chemotherapy with stem cell rescue and external beam radiotherapy. (research) (no timestamp yet)
- Therapy was concluded with a maintenance course of bevacizumab in one patient. (research) (no timestamp yet)
- The patients are disease-free 7 years and 30 months, respectively, after diagnosis. (research) (no timestamp yet)
- With aggressive multimodal therapy SCCOHT is curable in children. (research) (no timestamp yet)

---
Educational content from recorded physician discussions — not medical advice. Cite the canonical URL or the ?t= deep link. Policy: https://library.globalcastmd.com/ai
